register

News & Trends - Pharmaceuticals

TGA cautions against over-buying medicines

Health Industry Hub | March 17, 2020 |

Pharma News: In response to COVID-19, the TGA is aware that some pharmacists have been over-ordering medicines, while many consumers have been over-buying. This has resulted in some temporary local level out-of-stock situations, which we expect will resolve in the coming week or two.

It is important to understand that a local out-of-stock is not a national medicine shortage.

The large spike in orders from some pharmacies has resulted in other pharmacies not getting the stock they need. This means that consumers may be unable to get the medicines they need.

Stockpiling medicines may disrupt access to vital medicines by patients and pharmacies.

We call on consumers not to purchase more medicines than they need, and we urge health professionals to reassure patients that there is no need to buy more than is necessary. Health professionals should also avoid prescribing or dispensing multiple months of supply of prescription medicines to patients where there is no clinical need to do so.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

We call on pharmacists to avoid over ordering medicines, to help ensure that medicines are available to all Australians who need them.

The Department of Health is closely monitoring medicines supply, and working with sponsors, wholesalers and health professional groups to identify and address issues relating to supply.

Australian law requires medicines companies to report current and anticipated shortages of prescription medicines and certain over-the-counter medicines.

We publish shortage notifications for the information of health professionals and consumers, which you can find on the Medicine Shortages Information Initiative web page.

Sponsors are required to report all shortages of reportable medicines. To date, the TGA has not been notified of any medicine shortage as a direct result of the coronavirus.

Customer engagement in COVID-19 times – Keep your people safe and maximise HCP reach digitally. Learn more about how we can assist your team – developed by industry for industry.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.